None
Quote | Aquestive Therapeutics Inc. (NASDAQ:AQST)
Last: | $4.07 |
---|---|
Change Percent: | -1.78% |
Open: | $4 |
Close: | $4.07 |
High: | $4.2497 |
Low: | $3.95 |
Volume: | 1,963,042 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
News | Aquestive Therapeutics Inc. (NASDAQ:AQST)
2024-04-27 08:09:56 ET More on Aquestive Therapeutics Aquestive Therapeutics: Positive Phase III Data Unlocks Additional Catalysts For 2024 Aquestive Therapeutics, Inc. (AQST) Q4 2023 Earnings Call Transcript Aquestive Therapeutics, Inc. 2023 Q4 - Results - Earnings ...
WARREN, N.J., April 25, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technolo...
Message Board Posts | Aquestive Therapeutics Inc. (NASDAQ:AQST)
Subject | By | Source | When |
---|---|---|---|
Toxic slobs is more like it. | trendzone | investorshub | 09/27/2022 9:59:43 PM |
On going S-3 shelf placement! | crudeoil24 | investorshub | 09/27/2022 11:33:33 AM |
Aquestive Therapeutics Announces EPIPHAST II Trial Data For | crudeoil24 | investorshub | 09/27/2022 11:29:53 AM |
znewcar1: AQST 24% v2,2M c1.73 f53,4M H1.78 ML.78 LL.62 nice turn Haft1.98 | znewcar1 | investorshangout | 08/12/2022 8:48:36 PM |
https://www.stockscores.com/chart.asp?TickerSymbol=aqst%20&TimeRange=1825&Interv | The Night Stalker | investorshub | 07/23/2022 4:56:05 PM |
News, Short Squeeze, Breakout and More Instantly...
Aquestive Therapeutics Inc. Company Name:
AQST Stock Symbol:
NASDAQ Market:
Aquestive Therapeutics Inc. Website:
WARREN, N.J., April 25, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technolo...
U.S. stocks were lower, with the Nasdaq Composite falling over 50 points on Thursday. Shares of Ally Financial Inc. (NYSE:ALLY) rose sharply during...